Better Context → Better Decisions
Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers with corporate access will find a wealth of contextualized life science insight ready to be viewed in the FENIX Marketplace.
Welcome to FENIX Syndicated Services. If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact us.
$599
Posted in: Glucagon, Other Sep 04 | 2020Danilo Verge and David Kendall Join ZealandPurchase Blast
$599
Posted in: Autologous, CAR-T, CD19 Sep 04 | 2020Gilead Highlights No Impact of COVID-19 on Yescarta Sales; Two New LCM Initiatives for Yescarta; Q2 2020 Earnings Call SummaryPurchase Blast
$599
Posted in: Autologous, BCMA, CAR-T Sep 03 | 2020bluebird bio Highlights Ide-cel Resubmission; Q2 2020 Earnings CallPurchase Blast
$599
Posted in: Other Sep 02 | 2020Former Head of BI Diabetes/CardioMetabolism Joins NovoPurchase Blast
$599
Posted in: Glucose Monitoring Sep 01 | 2020Libre 2 Available for Medicare Patients; Senseonics Receives Positive Medicare Local Coverage DeterminationsPurchase Blast
$599
Posted in: SGLT2i Sep 01 | 2020AZ Provides Additional DAPA-CKD Commentary During Post-Results Investor CallPurchase Blast
$599
Posted in: BCMA, CAR-T, CD19 Sep 01 | 2020Thoughts on Allogene’s AlloCAR Program; Q2 2020 Earnings Call SummaryPurchase Blast
$599
Posted in: BCMA, CAR-T, CD19 Sep 01 | 2020BMS Highlights Ide-cel FDA Re-submission; Q2 2020 Earnings CallPurchase Blast
$599
Posted in: Insulin Delivery Aug 31 | 2020Medtronic's 770G Pump Approved in Peds Down to 2 Years of AgePurchase Blast
$599
Posted in: GLP-1RA Aug 31 | 2020New Oral Sema High-Dose and Flexible Administration Ph1 Trials from NovoPurchase Blast
$599
Posted in: Basal Insulin Aug 31 | 2020Biocon/Mylan Launch Semglee in US at 65% WAC Discount to LantusPurchase Blast
$599
Posted in: Autologous, CAR-T, CD19 Aug 31 | 2020Thoughts on Gilead's Recent FDA Approval for Tecartus (KTE-X19) in R/R Mantle Cell LymphomaPurchase Blast$599
Posted in: SGLT2i Aug 30 | 2020DAPA-CKD Results Highly Positive; AZ Winning in SGLT2i LCMPurchase Blast
$599
Posted in: Basal Insulin Aug 27 | 2020Lannett To Forego Bs-Glargine U100 Interchangeability; Lannett Q2 '20 Earnings UpdatePurchase Blast
$599
Posted in: Glucose Monitoring, Insulin Delivery Aug 25 | 2020Medtronic CY Q2 ’20 (FY Q1 ’21) Earnings UpdatePurchase Blast
$599
Posted in: Autologous, CAR-T, CD19 Aug 25 | 2020Kymriah Sales Unaffected By COVID-19, but Ph3 Adult ALL Trial Withdrawn; Novartis Q2 2020 Earnings UpdatePurchase Blast
$599
Posted in: Glucose Monitoring, Other Aug 24 | 2020Bayer Commits ~$100M in One Drop Series CPurchase Blast